Expression of a recombinant Fab antibody fragment against cruzipain, the major cysteine proteinase of Trypanosoma cruzi
Cruzipain, the major proteinase of Trypanosoma cruzi, plays an important role in the biology of this parasite. This study reports the development of a recombinant Fab antibody, using RNA isolated from the anti-Ag163B6 hybridoma against cruzipain. This procedure involves the use of cDNAs obtained wit...
Autor principal: | |
---|---|
Otros Autores: | , , , , , |
Formato: | Capítulo de libro |
Lenguaje: | Inglés |
Publicado: |
Academic Press Inc.
1998
|
Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
Aporte de: | Registro referencial: Solicitar el recurso aquí |
LEADER | 08069caa a22011177a 4500 | ||
---|---|---|---|
001 | PAPER-19712 | ||
003 | AR-BaUEN | ||
005 | 20240412203504.0 | ||
008 | 190411s1998 xx ||||fo|||| 00| 0 eng|d | ||
024 | 7 | |2 scopus |a 2-s2.0-0032501431 | |
024 | 7 | |2 Molecular Sequence Numbers |a GENBANK: AF091431; | |
024 | 7 | |2 cas |a cruzipain; cysteine proteinase, 37353-41-6; RNA, 63231-63-0 | |
030 | |a BBRCA | ||
040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
100 | 1 | |a Kaplan, D. | |
245 | 1 | 0 | |a Expression of a recombinant Fab antibody fragment against cruzipain, the major cysteine proteinase of Trypanosoma cruzi |
260 | |b Academic Press Inc. |c 1998 | ||
270 | 1 | 0 | |m Baldi, A.; IBYME, Obligado 2490, (1428) Buenos Aires, Argentina; email: abaldi@proteus.dna.uba.ar |
504 | |a Brener, Z., (1982) Bull. World Health Organ., 60, pp. 463-473 | ||
504 | |a (1984) World Health Organ. Tech. Report. Ser., 701, pp. 53-60 | ||
504 | |a Chiller, T.M., Samudio, M.A., Zoulek, G., (1990) Am. J. Trop. Med. Hyg., 22, pp. 696-698 | ||
504 | |a Malchiodi, E.L., Chiaramonte, M.G., Taranto, N.J., Zwirner, N.W., Margni, R.A., (1994) Clin. Exp. Immunol., 97, pp. 417-423 | ||
504 | |a Camargo, M.E., (1988) Laboratory Diagnosis of Infectious Disease, Principles and Practice, 1, pp. 744-753. , Springer Verlag, New York | ||
504 | |a Schattschneider, W., Lopes, E.R., De Alencar, J.E., (1992) Trop. Geogr. Med., 44, pp. 210-218 | ||
504 | |a Chiaramonte, M.G., Zwirner, N.W., Caropresi, S.L., Taranto, N.J., Malchiodi, E.L., (1996) Am. J. Trop. Med. Hyg., 54 (3), pp. 271-273 | ||
504 | |a Malchiodi, E.L., Chiaramonte, M.G., Martinez, J.A., Zwirner, N.W., Margni, R.A., Cazzulo, J.J., (1993) Immunol. Lett., 35, pp. 59-62 | ||
504 | |a Martinez, J., Campetella, O., Frasch, A.C.C., Cazzulo, J.J., (1991) Infect. Immunity, 59, p. 4275 | ||
504 | |a Carbonetto, C.H., Malchiodi, E.L., Chiaramonte, M.G., Durante De Isola, E., Fossati, C.A., Margni, R.A., (1990) Clin. Exp. Immunol., 82, pp. 93-96 | ||
504 | |a Cabilly, S., Rigss, A.D., Pande, H., Shively, J.E., Holmes, W.E., Rey, M., Perry, L.J., Heyneker, H.L., (1984) Proc. Natl. Acad. Sci. USA, 81, pp. 3273-3277 | ||
504 | |a Barbas C.F. III, Kang, A.S., Lerner, R.A., Benkovic, S.J., (1991) Proc. Natl. Acad. Sci. USA, 88, pp. 7978-7982 | ||
504 | |a Huse, W.D., Sastry, L., Iverson, S.A., Kang, A.S., Alting-Mees, M., Burton, D.R., Benkovic, S.J., Lerner, R.A., (1989) Science, 246, pp. 1275-1281 | ||
504 | |a Sambrook, J., Fritsch, E.F., Maniatis, T., (1989), Cold Spring Harbor Laboratory Press; Alvarez, M., Cerisola, J.A., Rohwedder, R.W., (1968) Bol. Chile Parasitol., 23, pp. 4-9 | ||
504 | |a Goldbaum, F.A., Leoni, J., Wallace, J.C., Fossati, C.A., (1993) J. Clin. Microbiol., 31, pp. 2141-2145 | ||
504 | |a Levin, M.J., Franco Da Silveira, J., Frasch, A.C.C., Camargo, M.E., Lafon, S., Degrave, W.M., Rangel Aldao, R., (1991) FEMS Microbiol. Immunol., 89, pp. 11-20 | ||
504 | |a Kaplan, D., Ferrari, I., Lopez Bergami, P., Mahler, E., Levitus, G., Chiale, P., Hoebeke, J., Levin, M., (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 10301-10306 | ||
504 | |a Viotti, R., Vigliano, C., Armenti, H., Segura, E., (1994) Am. Heart J., 127, pp. 151-162 | ||
504 | |a Franke De Cazzulo, B.M., Martinez, J., North, M.J., Coombs, G.H., Cazzulo, J.J., (1994) FEMS Microbiol. Lett., 124, pp. 81-86 | ||
504 | |a Meirelles, M.N., Juliano, L., Carmona, E., Silva, S.G., Costa, E.M., Murta, A.C., Scharfstein, J., (1992) Mol. Biochem. Parasitol., 52, pp. 175-184 | ||
504 | |a Cazzulo, J.J., Stoka, V., Turk, V., (1997) J. Biol. Chem., 378, pp. 1-10 | ||
504 | |a Gonzalez, G., Orn, A., Cazzulo, J.J., Gronvik, K.O., (1994) Scand. J. Immunol., 40, pp. 389-394 | ||
504 | |a McGrath, M.E., Eakin, A.E., Engel, J.C., McKerrow, J.H., Craik, C.S., Fletterick, R.J., (1995) J. Mol. Biol., 247, pp. 251-259 | ||
504 | |a Lalmanach, G., Mayer, R., Serveau, C., Scharfstein, J., Gauthier, F., (1996) Biochem. J., 318, pp. 395-399 | ||
506 | |2 openaire |e Política editorial | ||
520 | 3 | |a Cruzipain, the major proteinase of Trypanosoma cruzi, plays an important role in the biology of this parasite. This study reports the development of a recombinant Fab antibody, using RNA isolated from the anti-Ag163B6 hybridoma against cruzipain. This procedure involves the use of cDNAs obtained with the aid of a specific set of primers complementary to the complete light kappa chain (Lκ) and the first two domains of the IgG1 heavy chain (VH/CH1). These products were subsequently cloned in the pComb3 system, from which the gIII gene had been removed, and expressed in Escherichia coli cells. The recombinant Fab molecule recognized cruzipain by ELISA, in a fashion similar to the original mAb anti Ag163B6. Nucleotide sequence analysis of the recombinant molecule, together with its immunological recognition by specific anti-mouse IgG (Fab)2, indicated the immunoglobulin nature of the recombinant product. Moreover, both the mAb anti-Ag163B6 and the soluble Fab fragment described here react similarly with the intact parasite surface, as observed in an indirect immunofluorescence assay. In conclusion, our recombinant Fab anti-Ag163B6 allows the possible use of this molecule for diagnosis, antigen purification, and eventually treatment of Chagas-afflicted individuals. |l eng | |
536 | |a Detalles de la financiación: Universidad de Buenos Aires, UBA | ||
536 | |a Detalles de la financiación: National Research Council, NRC | ||
536 | |a Detalles de la financiación: This work was financially supported by National Research Council (CONICET-Argentina) and University of Buenos Aires (UBA). | ||
593 | |a Inst. of Biol./Exp. Medicine (IBYME), Obligado 2490, 1428, Buenos Aires, Argentina | ||
593 | |a Inst. of Humoral Immunity Studies, IDEHU, CONICET-UBA, Buenos Aires, Argentina | ||
593 | |a Inst. of Genetic Eng./Molec. Biology, CONICET-UBA, Buenos Aires, Argentina | ||
690 | 1 | 0 | |a COMPLEMENTARY DNA |
690 | 1 | 0 | |a CRUZIPAIN |
690 | 1 | 0 | |a CYSTEINE PROTEINASE |
690 | 1 | 0 | |a ENZYME ANTIBODY |
690 | 1 | 0 | |a IMMUNOGLOBULIN F(AB) FRAGMENT |
690 | 1 | 0 | |a IMMUNOGLOBULIN HEAVY CHAIN |
690 | 1 | 0 | |a IMMUNOGLOBULIN KAPPA CHAIN |
690 | 1 | 0 | |a PARASITE ANTIBODY |
690 | 1 | 0 | |a PARASITE ANTIGEN |
690 | 1 | 0 | |a PRIMER DNA |
690 | 1 | 0 | |a RECOMBINANT ANTIBODY |
690 | 1 | 0 | |a RNA |
690 | 1 | 0 | |a ANIMAL CELL |
690 | 1 | 0 | |a ANTIGEN RECOGNITION |
690 | 1 | 0 | |a ARTICLE |
690 | 1 | 0 | |a CONTROLLED STUDY |
690 | 1 | 0 | |a ENZYME LINKED IMMUNOSORBENT ASSAY |
690 | 1 | 0 | |a ESCHERICHIA COLI |
690 | 1 | 0 | |a GENE EXPRESSION SYSTEM |
690 | 1 | 0 | |a HYBRIDOMA |
690 | 1 | 0 | |a IMMUNOFLUORESCENCE |
690 | 1 | 0 | |a MOLECULAR CLONING |
690 | 1 | 0 | |a NONHUMAN |
690 | 1 | 0 | |a NUCLEOTIDE SEQUENCE |
690 | 1 | 0 | |a PRIORITY JOURNAL |
690 | 1 | 0 | |a TRYPANOSOMA CRUZI |
690 | 1 | 0 | |a ANIMALIA |
690 | 1 | 0 | |a ESCHERICHIA COLI |
690 | 1 | 0 | |a ESCHERICHIA COLI |
690 | 1 | 0 | |a TRYPANOSOMA |
690 | 1 | 0 | |a TRYPANOSOMA CRUZI |
690 | 1 | 0 | |a TRYPANOSOMA CRUZI |
700 | 1 | |a Baldi, C. | |
700 | 1 | |a Chiaramonte, M.G. | |
700 | 1 | |a Fernandez, M.M. | |
700 | 1 | |a Levin, M.J. | |
700 | 1 | |a Malchiodi, E. L. | |
700 | 1 | |a Baldi, A. | |
773 | 0 | |d Academic Press Inc., 1998 |g v. 253 |h pp. 53-58 |k n. 1 |p Biochem. Biophys. Res. Commun. |x 0006291X |w (AR-BaUEN)CENRE-905 |t Biochemical and Biophysical Research Communications | |
856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032501431&doi=10.1006%2fbbrc.1998.9654&partnerID=40&md5=8235b5a9dbbc62d31079c688760ca309 |x registro |y Registro en Scopus |
856 | 4 | 0 | |u https://doi.org/10.1006/bbrc.1998.9654 |x doi |y DOI |
856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_0006291X_v253_n1_p53_Kaplan |y Handle |
856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0006291X_v253_n1_p53_Kaplan |x registro |y Registro en la Biblioteca Digital |
961 | |a paper_0006291X_v253_n1_p53_Kaplan |b paper |c PE | ||
962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
963 | |a VARI |